Jeff Fensterer
Chief Operating OfficerMr. Jeff Fensterer is Chief Operating Officer of AccuStem Sciences, Inc. from March 1, 2025. Mr. Fensterer served as Chief Operating Officer of Accustem Sciences Inc. since March 2022 until June 16, 2023. He served as Chief Operating Officer of AccuStem Sciences Limited since December 2021. He has an exceptional track record in long term strategic planning that is enhanced by his experience in a broad spectrum of roles including marketing, sales, market access, lab operations and product development. He has spent years with startups at various organizational stages, leading marketing and product strategy in his most recent roles at Agendia, Animated Dynamics and Biodesix. His scientific expertise and keen commercial perspective enable organizations to take clinical data and translate it into impactful product messaging and publication strategies. His exceptional track record in long-term strategic planning is enhanced by experience in a broad spectrum of roles including marketing, sales, R&D, market access, lab operations, clinical development, business development and IT. Mr. Fensterer received an MBA from Carnegie Mellon Tepper School of Business in May 2015 and a BS degree from Saint Vincent College in May 2001.
Positions
- Company NameAccuStem Sciences, Inc.Stock CodeACUTPositionChief Operating Officer
